Continuing Enhanced National Surveillance for Prion Diseases in the United States
The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 2022 funds for a cooperative agreement program to continue enhanced national surveillance for human prion diseases in the United States.
The purpose of the funding is to continue an active surveillance program similar to that conducted by the National Prion Disease Pathology Surveillance Center (NPDPSC) since 1997 to monitor the occurrence of potentially emerging human transmissible spongiform encephalopathies (TSEs) in the United States.
In 1997, in collaboration with the American Association of Neuropathologists (AANP), the National Prion Disease Pathology Surveillance Center was established to enhance national CJD surveillance and to make possible laboratory investigation of newly emerging prion diseases.
This pathology center, currently located at Case Western Reserve University in Cleveland, Ohio, provided the services of a cutting edge prion disease laboratory, filling a critical public health gap for monitoring prion diseases in humans.
Brain tissues and clinical laboratory information on clinically suspected and diagnosed cases of human prion disease have been evaluated at the NPDPSC for approximately 20 years to confirm diagnoses and determine the type of prion disease, including whether the patients had variant CJD or some other possible emerging prion disease in the United States.
The purpose of the funding is to continue an active surveillance program similar to that conducted by the National Prion Disease Pathology Surveillance Center (NPDPSC) since 1997 to monitor the occurrence of potentially emerging human transmissible spongiform encephalopathies (TSEs) in the United States.
In 1997, in collaboration with the American Association of Neuropathologists (AANP), the National Prion Disease Pathology Surveillance Center was established to enhance national CJD surveillance and to make possible laboratory investigation of newly emerging prion diseases.
This pathology center, currently located at Case Western Reserve University in Cleveland, Ohio, provided the services of a cutting edge prion disease laboratory, filling a critical public health gap for monitoring prion diseases in humans.
Brain tissues and clinical laboratory information on clinically suspected and diagnosed cases of human prion disease have been evaluated at the NPDPSC for approximately 20 years to confirm diagnoses and determine the type of prion disease, including whether the patients had variant CJD or some other possible emerging prion disease in the United States.
Related Programs
Prevention of Disease, Disability, and Death by Infectious Diseases
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control - NCEZID
Estimated Funding: $20,000,000
Office: Centers for Disease Control - NCEZID
Estimated Funding: $20,000,000
Who's Eligible
Obtain Full Opportunity Text:
https://acl.gov/grants/open-opportunities
Additional Information of Eligibility:
Hospitals, Laboratories and other public and/or private entities may apply.
Full Opportunity Web Address:
https://acl.gov/grants/open-opportunities
Contact:
Agency Email Description:
TPonder@cdc.gov
Agency Email:
Date Posted:
2022-01-28
Application Due Date:
Archive Date:
2022-04-28
Social Entrepreneurship
Spotlight
When it Comes to Social Enterprises, Failure is the Best Platform for Innovation
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.
Learn How to Identify and Avoid Grant Scams
